Depot Disulfiram for AIDS and ARC

S

St. Vincent's Medical Center

Status

Completed

Conditions

HIV Infections

Treatments

Drug: Disulfiram

Study type

Interventional

Funder types

Other

Identifiers

NCT00002065
024A

Details and patient eligibility

About

To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.

  • Also patient must be:
  • Able to understand the study.
  • Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
  • Ambulatory and able to maintain an independent life outside the hospital.
  • Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

History of alcohol abuse.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems